Arthur Pharma

Arthur Pharma is a specialty pharmaceutical company focused on the research, development, and manufacturing of high-end generic and innovative drug products. Headquartered in Jiaxing, China, with a significant R&D presence in the United States, the company specializes in complex formulations, including high-potency injectables and difficult-to-synthesize small molecules. Their therapeutic focus spans cardiovascular diseases, oncology, and central nervous system disorders. Arthur Pharma maintains state-of-the-art facilities that meet global regulatory standards, enabling them to supply products to major international markets including the US, EU, and China. The company's strategy emphasizes high-barrier-to-entry products and value-added medicines. They operate as a vertically integrated entity with capabilities ranging from API synthesis to finished dosage form production.